
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Pharmacy from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/pharmacy/topic/2233/</link>
        <description>Articles tagged with Pharmacy from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Business briefs: Pfizer and CVS; the EMA; Digitas Health New York</title>
          <description>Pfizer&apos;s online Viagra deal with CVS; reorg at the EMA; Mills moves up at Digitas</description>
          <link>http://www.mmm-online.com/business-briefs-pfizer-and-cvs-the-ema-digitas-health-new-york/article/292169/</link>
          <pubDate>Mon, 06 May 2013 19:40:21 GMT</pubDate>
          <itunes:summary>Pfizer&apos;s online Viagra deal with CVS; reorg at the EMA; Mills moves up at Digitas</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Remedy offers docs (and advertisers) a platform for direct communication with patients</title>
          <description>Remedy Health is looking to close the loop—and sell advertising off of it—with the launch of a service letting doctors, pharmacies and other healthcare providers send topical health content to their patients.</description>
          <link>http://www.mmm-online.com/remedy-offers-docs-and-advertisers-a-platform-for-direct-communication-with-patients/article/269475/</link>
          <pubDate>Wed, 28 Nov 2012 14:00:00 GMT</pubDate>
          <itunes:summary>Remedy Health is looking to close the loop—and sell advertising off of it—with the launch of a service letting doctors, pharmacies and other healthcare providers send topical health content to their patients.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Op/Ed: Meningitis crisis and the threat to pharma</title>
          <description>The deadly meningitis outbreak highlights the threat not only to public health, but also to the pharma industry, posed by the largely unregulated practice of pharmacy compounding.</description>
          <link>http://www.mmm-online.com/oped-meningitis-crisis-and-the-threat-to-pharma/article/263094/</link>
          <pubDate>Wed, 10 Oct 2012 19:06:58 GMT</pubDate>
          <itunes:summary>The deadly meningitis outbreak highlights the threat not only to public health, but also to the pharma industry, posed by the largely unregulated practice of pharmacy compounding.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: FDA, Ranbaxy, Daiichi Sankyo and ImpactRx</title>
          <description>The FDA issued Driving Innovation, a blueprint for fostering American biomedical innovation, reiterating a prior commitment to reform regulation and announcing policies aimed at facilitating personalized medicine.</description>
          <link>http://www.mmm-online.com/company-news-fda-ranbaxy-daiichi-sankyo-and-impactrx/article/213767/</link>
          <pubDate>Thu, 06 Oct 2011 17:42:19 GMT</pubDate>
          <itunes:summary>The FDA issued Driving Innovation, a blueprint for fostering American biomedical innovation, reiterating a prior commitment to reform regulation and announcing policies aimed at facilitating personalized medicine.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: K-V Pharmaceutical and Ther-Rx</title>
          <description>In a blow to K-V Pharmaceutical, the FDA said it will not take action against pharmacies that make hydroxyprogesterone caproate, the active ingredient in K-V&apos;s recently approved pre-term labor prevention drug Makena.</description>
          <link>http://www.mmm-online.com/company-news-k-v-pharmaceutical-and-ther-rx/article/199700/</link>
          <pubDate>Thu, 31 Mar 2011 18:55:30 GMT</pubDate>
          <itunes:summary>In a blow to K-V Pharmaceutical, the FDA said it will not take action against pharmacies that make hydroxyprogesterone caproate, the active ingredient in K-V&apos;s recently approved pre-term labor prevention drug Makena.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Walgreens partners with Epocrates to highlight drug rebates</title>
          <description>Walgreens is hoping physicians will consider its &quot;Prescription Savings Club&quot; list of over 8,000 brand and generic drugs before deciding which script to write for underinsured or cash-strapped patients. Epocrates will provide point of care access to the list via mobile device starting today.</description>
          <link>http://www.mmm-online.com/walgreens-partners-with-epocrates-to-highlight-drug-rebates/article/181347/</link>
          <pubDate>Wed, 20 Oct 2010 19:20:13 GMT</pubDate>
          <itunes:summary>Walgreens is hoping physicians will consider its &quot;Prescription Savings Club&quot; list of over 8,000 brand and generic drugs before deciding which script to write for underinsured or cash-strapped patients. Epocrates will provide point of care access to the list via mobile device starting today.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Novartis exploits J&amp;J recall pains with Triaminic giveaway</title>
          <description>Novartis is capitalizing on rival J&amp;J&apos;s woes with a giveaway of its new Triaminic OTC children&apos;s acetaminophen.</description>
          <link>http://www.mmm-online.com/novartis-exploits-jj-recall-pains-with-triaminic-giveaway/article/175879/</link>
          <pubDate>Thu, 29 Jul 2010 20:01:28 GMT</pubDate>
          <itunes:summary>Novartis is capitalizing on rival J&amp;J&apos;s woes with a giveaway of its new Triaminic OTC children&apos;s acetaminophen.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Scripts going unfilled at &apos;unprecedented&apos; rate</title>
          <description>Patients not taking or refilling medications on time costs the pharmaceutical industry billions each year. The housing bubble and recession have helped write a new chapter in the compliance story, as higher numbers of new prescriptions simply go unfilled because patients either cannot afford, or are unwilling, to pay for them.</description>
          <link>http://www.mmm-online.com/scripts-going-unfilled-at-unprecedented-rate/article/165918/</link>
          <pubDate>Tue, 16 Mar 2010 19:38:08 GMT</pubDate>
          <itunes:summary>Patients not taking or refilling medications on time costs the pharmaceutical industry billions each year. The housing bubble and recession have helped write a new chapter in the compliance story, as higher numbers of new prescriptions simply go unfilled because patients either cannot afford, or are unwilling, to pay for them.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pharmacy adherence pilot boosted refills 36%</title>
          <description>Pharmacies that counseled patients for a chronic COPD/respiratory drug saw an average increase in refill rates of more than 36% through the fifth fill, said McKesson.</description>
          <link>http://www.mmm-online.com/pharmacy-adherence-pilot-boosted-refills-36/article/159084/</link>
          <pubDate>Fri, 04 Dec 2009 19:54:46 GMT</pubDate>
          <itunes:summary>Pharmacies that counseled patients for a chronic COPD/respiratory drug saw an average increase in refill rates of more than 36% through the fifth fill, said McKesson.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Cardinal Health launches in-pharmacy ad network</title>
          <description>Cardinal Health launched the Pharmacy Health Network in early August, serving up digital prescription and OTC advertising in 3,000 independent retail and franchised pharmacies nationwide.</description>
          <link>http://www.mmm-online.com/cardinal-health-launches-in-pharmacy-ad-network/article/146722/</link>
          <pubDate>Tue, 18 Aug 2009 17:22:54 GMT</pubDate>
          <itunes:summary>Cardinal Health launched the Pharmacy Health Network in early August, serving up digital prescription and OTC advertising in 3,000 independent retail and franchised pharmacies nationwide.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  